Rockwell Medical (RMTI) Change in Acquisitions & Divestments (2012 - 2026)
Rockwell Medical (RMTI) posted Change in Acquisitions & Divestments of $7.2 million for Q1 2026, little changed on a QoQ basis from $7.2 million in Q4 2025, and up 140.0% year-over-year from $3.0 million in Q1 2025.
Rockwell Medical (RMTI) Change in Acquisitions & Divestments (2012 - 2026) Analysis & Trends
Rockwell Medical's Change in Acquisitions & Divestments history runs 12 years deep, the most recent figure standing at $7.2 million for Q1 2026.
- Quarterly Change in Acquisitions & Divestments rose 140.0% year-over-year to $7.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $20.4 million (up 307.76% YoY) and the FY2025 annual result came in at $16.2 million, up 708.79% from the prior year.
- Change in Acquisitions & Divestments was $7.2 million for Q1 2026 at Rockwell Medical, roughly flat from $7.2 million in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $12.0 million in Q1 2022 and bottomed at $1.8 million in Q2 2023.
- A 5-year average of $5.0 million and a median of $3.5 million in 2023 frame the typical range for Change in Acquisitions & Divestments.
- Annual changes were most pronounced in 2023 — Change in Acquisitions & Divestments tumbled 44.52% — and 2026, when it jumped 140.0%.
- Rockwell Medical's Change in Acquisitions & Divestments stood at $7.2 million in 2022, then tumbled by 44.52% to $4.0 million in 2023, then slumped by 49.92% to $2.0 million in 2024, then soared by 259.46% to $7.2 million in 2025, then changed by 0.0% to $7.2 million in 2026.
- Business Quant data shows RMTI's Change in Acquisitions & Divestments at $7.2 million in Q1 2026, $7.2 million in Q4 2025, and $3.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Rockwell Medical | 27.99 Mn | 4.10 Mn | 2.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.20 Mn |
| Mar 31, 2026 | 7.20 Mn |
| Dec 31, 2025 | 7.20 Mn |
| Dec 31, 2025 | 7.20 Mn |
| Sep 30, 2025 | 3.00 Mn |
| Sep 30, 2025 | 3.00 Mn |
| Jun 30, 2025 | 3.00 Mn |
| Jun 30, 2025 | 3.00 Mn |
| Mar 31, 2025 | 3.00 Mn |
| Mar 31, 2025 | 3.00 Mn |
| Jun 30, 2024 | 2.00 Mn |
| Jun 30, 2024 | 2.00 Mn |
| Dec 31, 2023 | 4.00 Mn |
| Dec 31, 2023 | 4.00 Mn |
| Sep 30, 2023 | 2.00 Mn |
| Sep 30, 2023 | 2.00 Mn |
| Jun 30, 2023 | 1.80 Mn |
| Jun 30, 2023 | 1.80 Mn |
| Mar 31, 2023 | 7.50 Mn |
| Mar 31, 2023 | 7.50 Mn |